| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Macrocephaly | 2.46e-05 | 491 | 15 | 8 | HP:0000256 | |
| HumanPheno | Increased head circumference | 2.81e-05 | 500 | 15 | 8 | HP:0040194 | |
| Domain | DUF4599 | 3.45e-06 | 12 | 48 | 3 | PF15371 | |
| Domain | DUF4599 | 3.45e-06 | 12 | 48 | 3 | IPR027970 | |
| Domain | AT_hook | 4.46e-05 | 27 | 48 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.46e-05 | 27 | 48 | 3 | IPR017956 | |
| Domain | - | 4.20e-04 | 12 | 48 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 4.20e-04 | 12 | 48 | 2 | IPR010919 | |
| Domain | AT_hook | 7.58e-04 | 16 | 48 | 2 | PF02178 | |
| Domain | GUANYLATE_KINASE_2 | 1.58e-03 | 23 | 48 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.58e-03 | 23 | 48 | 2 | PS00856 | |
| Domain | Guanylate_kin | 2.02e-03 | 26 | 48 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.02e-03 | 26 | 48 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.02e-03 | 26 | 48 | 2 | IPR008144 | |
| Domain | GuKc | 2.02e-03 | 26 | 48 | 2 | SM00072 | |
| Domain | SH2 | 2.23e-03 | 101 | 48 | 3 | PF00017 | |
| Domain | SH3 | 2.27e-03 | 216 | 48 | 4 | SM00326 | |
| Domain | SH3 | 2.27e-03 | 216 | 48 | 4 | PS50002 | |
| Domain | SH3_domain | 2.43e-03 | 220 | 48 | 4 | IPR001452 | |
| Domain | SH2 | 2.84e-03 | 110 | 48 | 3 | SM00252 | |
| Domain | HMGI/Y_DNA-bd_CS | 2.87e-03 | 31 | 48 | 2 | IPR000637 | |
| Domain | SH2 | 2.91e-03 | 111 | 48 | 3 | PS50001 | |
| Domain | SH2 | 2.98e-03 | 112 | 48 | 3 | IPR000980 | |
| Domain | - | 2.98e-03 | 112 | 48 | 3 | 3.30.505.10 | |
| Domain | - | 4.74e-03 | 40 | 48 | 2 | 4.10.1000.10 | |
| Domain | WW | 6.49e-03 | 47 | 48 | 2 | PF00397 | |
| Domain | ZnF_C3H1 | 6.77e-03 | 48 | 48 | 2 | SM00356 | |
| Domain | WW | 6.77e-03 | 48 | 48 | 2 | SM00456 | |
| Domain | zf-CCCH | 7.04e-03 | 49 | 48 | 2 | PF00642 | |
| Domain | WW_DOMAIN_2 | 7.61e-03 | 51 | 48 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 7.61e-03 | 51 | 48 | 2 | PS01159 | |
| Domain | WW_dom | 7.90e-03 | 52 | 48 | 2 | IPR001202 | |
| Domain | SH3_1 | 8.61e-03 | 164 | 48 | 3 | PF00018 | |
| Domain | - | 9.43e-03 | 57 | 48 | 2 | 3.30.50.10 | |
| Domain | Znf_CCCH | 9.76e-03 | 58 | 48 | 2 | IPR000571 | |
| Domain | Znf_NHR/GATA | 9.76e-03 | 58 | 48 | 2 | IPR013088 | |
| Domain | ZF_C3H1 | 9.76e-03 | 58 | 48 | 2 | PS50103 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TSC22D1 MTF1 ESR1 SKOR2 MLLT3 POU2F2 CAMTA2 RERE SP110 ZBTB24 SP7 | 4.26e-08 | 908 | 49 | 11 | 19274049 |
| Pubmed | 3.75e-07 | 486 | 49 | 8 | 20936779 | ||
| Pubmed | 2.44e-06 | 152 | 49 | 5 | 38360978 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 30257098 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 20874815 | ||
| Pubmed | 2.53e-05 | 1429 | 49 | 10 | 35140242 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 12712467 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.08e-05 | 430 | 49 | 6 | 35044719 | |
| Pubmed | Cloning, chromosomal localization and expression pattern of the POU domain gene Oct-11. | 5.42e-05 | 8 | 49 | 2 | 8441607 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 27065334 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 10480874 | ||
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 17728669 | ||
| Pubmed | 1.31e-04 | 808 | 49 | 7 | 20412781 | ||
| Pubmed | 1.54e-04 | 191 | 49 | 4 | 24146773 | ||
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 19079262 | ||
| Pubmed | Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. | 1.75e-04 | 14 | 49 | 2 | 18022614 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.16e-04 | 877 | 49 | 7 | 20211142 | |
| Pubmed | 2.30e-04 | 16 | 49 | 2 | 19693267 | ||
| Pubmed | Genetically distinct subsets within ANCA-associated vasculitis. | 2.93e-04 | 18 | 49 | 2 | 22808956 | |
| Pubmed | Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape? | 2.93e-04 | 18 | 49 | 2 | 26921296 | |
| Pubmed | 3.27e-04 | 19 | 49 | 2 | 24564958 | ||
| Pubmed | 3.28e-04 | 233 | 49 | 4 | 37704626 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.54e-04 | 457 | 49 | 5 | 32344865 | |
| Pubmed | 4.83e-04 | 23 | 49 | 2 | 27655933 | ||
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 39012257 | ||
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 12403705 | ||
| Pubmed | 6.67e-04 | 27 | 49 | 2 | 19801982 | ||
| Pubmed | 7.18e-04 | 28 | 49 | 2 | 18067320 | ||
| Pubmed | 9.39e-04 | 32 | 49 | 2 | 19491387 | ||
| Pubmed | 1.12e-03 | 35 | 49 | 2 | 33864728 | ||
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 1.23e-03 | 149 | 49 | 3 | 25231870 | |
| Pubmed | 1.32e-03 | 38 | 49 | 2 | 14634838 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.40e-03 | 588 | 49 | 5 | 38580884 | |
| Interaction | EYA4 interactions | 1.22e-06 | 243 | 46 | 7 | int:EYA4 | |
| Cytoband | 9q21.32 | 1.09e-06 | 19 | 49 | 3 | 9q21.32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 1.28e-03 | 199 | 49 | 3 | chr9q21 | |
| GeneFamily | SH2 domain containing | 4.01e-04 | 101 | 26 | 3 | 741 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 6.33e-04 | 26 | 26 | 2 | 904 | |
| GeneFamily | Zinc fingers CCCH-type | 1.15e-03 | 35 | 26 | 2 | 73 | |
| GeneFamily | PDZ domain containing | 2.00e-02 | 152 | 26 | 2 | 1220 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 8.51e-06 | 155 | 47 | 5 | M8944 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.84e-05 | 199 | 47 | 5 | M5240 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 2.91e-05 | 200 | 47 | 5 | M9458 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 3.70e-05 | 36 | 47 | 3 | M4389 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 3.70e-05 | 36 | 47 | 3 | MM513 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.57e-08 | 196 | 49 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-06 | 198 | 49 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.10e-05 | 163 | 49 | 4 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.10e-05 | 163 | 49 | 4 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-05 | 173 | 49 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 175 | 49 | 4 | d544f24ee33783ed4afb4d7ec079a4484118bb15 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 4.27e-05 | 177 | 49 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 4.86e-05 | 183 | 49 | 4 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | CV-Moderate-4|CV / Virus stimulation, Condition and Cluster | 4.97e-05 | 184 | 49 | 4 | 90f5b447064743246b09a6c47bf561efafa15e1f | |
| ToppCell | CV-Moderate-4|Moderate / Virus stimulation, Condition and Cluster | 5.07e-05 | 185 | 49 | 4 | 4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 189 | 49 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.51e-05 | 189 | 49 | 4 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-05 | 190 | 49 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.63e-05 | 190 | 49 | 4 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.86e-05 | 192 | 49 | 4 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.86e-05 | 192 | 49 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.98e-05 | 193 | 49 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | 863765ccc0205dc28864dae85af339c283194c96 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 90 | 49 | 3 | 27865bd63dda0624e62a3b713464a490b588d3ae | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 90 | 49 | 3 | 8c2eb7444f938faade7c81a60c004252d588c80b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 90 | 49 | 3 | 4bc53b521abb79fc53ac912f1dc2e3c55426b2e0 | |
| ToppCell | Lymphoid-B_cells|World / shred on cell class and cell subclass (v4) | 5.64e-04 | 147 | 49 | 3 | aa4486200c523f2c9d3bad7a14f1764c2d92076b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.98e-04 | 150 | 49 | 3 | d6b977dd47aa017f6ba762f0c505cd896caa523f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-04 | 150 | 49 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.98e-04 | 150 | 49 | 3 | cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-04 | 150 | 49 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-04 | 151 | 49 | 3 | ee56b88c56c3b6a5ec9644c43cae521ea0e05920 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-04 | 151 | 49 | 3 | 2c239b09970acbaa90c5ebe1097f453c516f868e | |
| ToppCell | Lymphoid|World / shred on cell class and cell subclass (v4) | 6.10e-04 | 151 | 49 | 3 | d7577b2416b91a8be0198dea703385f86f816059 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.21e-04 | 152 | 49 | 3 | b750302d442160a1007659c2386ac90282bf95d2 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 153 | 49 | 3 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.58e-04 | 155 | 49 | 3 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.70e-04 | 156 | 49 | 3 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.70e-04 | 156 | 49 | 3 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-04 | 160 | 49 | 3 | 5c68d6a76c59e3a7e668ae5471396478a55756ac | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-04 | 160 | 49 | 3 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.21e-04 | 160 | 49 | 3 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-04 | 160 | 49 | 3 | 0fee84844733d36805e1df90ca09478169746708 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.21e-04 | 160 | 49 | 3 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-04 | 160 | 49 | 3 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.21e-04 | 160 | 49 | 3 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 162 | 49 | 3 | 8ed9149ff53b285591354057055d072b203a47c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 162 | 49 | 3 | 7a05b05a33e1309fb5c0a8171db105ae68491815 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 7.61e-04 | 163 | 49 | 3 | 4eac7fd8acdb7f09ce739335f22a879f9b8febfb | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 7.61e-04 | 163 | 49 | 3 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.61e-04 | 163 | 49 | 3 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 163 | 49 | 3 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 7.75e-04 | 164 | 49 | 3 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 165 | 49 | 3 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 7.88e-04 | 165 | 49 | 3 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-04 | 165 | 49 | 3 | 7039bb5a7af4684fbd1192230864e5cd6936e83c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-04 | 165 | 49 | 3 | d2c79653710b139794170f3d72f11392fc548ac7 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 165 | 49 | 3 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | -SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.02e-04 | 166 | 49 | 3 | bc9323de1373fdc0357e6bb46874f6c4787443a9 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.02e-04 | 166 | 49 | 3 | 30a180b67572c3f4fb3a291f271f855e1b20005e | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 8.31e-04 | 168 | 49 | 3 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.31e-04 | 168 | 49 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.31e-04 | 168 | 49 | 3 | 943687a33fffd7e19d906b9dd385a126bcea109a | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-04 | 169 | 49 | 3 | d44fc49056799dfc70a3c7d538c210d88ffded05 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-04 | 169 | 49 | 3 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-04 | 170 | 49 | 3 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | 6086d658a52a1961a1e293cbc3703ae8d309cd11 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.74e-04 | 171 | 49 | 3 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-04 | 171 | 49 | 3 | 656a9f407461dbf5c9c0bd234399e1fef6abce2a | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue | 8.74e-04 | 171 | 49 | 3 | eb47f4a09a630ed14a0898377039ed50ef7cc292 | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 8.74e-04 | 171 | 49 | 3 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.74e-04 | 171 | 49 | 3 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.74e-04 | 171 | 49 | 3 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-04 | 172 | 49 | 3 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-04 | 172 | 49 | 3 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-04 | 172 | 49 | 3 | 3784fd1e833703519889942e39fda991f03c3c76 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-04 | 172 | 49 | 3 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-04 | 172 | 49 | 3 | 995139aa38f8b9ff23166128b15476cd8a3ff1b8 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.89e-04 | 172 | 49 | 3 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-04 | 172 | 49 | 3 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-04 | 173 | 49 | 3 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-04 | 173 | 49 | 3 | 71c90c57225e452c73bf7bea46b454c472bf5f76 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-04 | 173 | 49 | 3 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-04 | 174 | 49 | 3 | d9489c4196d103ead8cb6279492bbe563a222e45 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 9.19e-04 | 174 | 49 | 3 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.19e-04 | 174 | 49 | 3 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-04 | 174 | 49 | 3 | aae7ab9df5a78716034ddfd5bd47adc69912d624 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.34e-04 | 175 | 49 | 3 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | 738b3d476ac494e2e79b70b3b83bc1b7ae8396bd | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 175 | 49 | 3 | bf1ef77d5fed2135ac83a4f7e445ab59d1538696 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-04 | 176 | 49 | 3 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.50e-04 | 176 | 49 | 3 | 318dc722b95e269002fb01a0feb91c0c8539e150 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 176 | 49 | 3 | 8caec727acae325a89a560ec44c933a635da496b | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.50e-04 | 176 | 49 | 3 | f6891006d816309edabe75b2abf60675f2958e55 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 9.50e-04 | 176 | 49 | 3 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 176 | 49 | 3 | dbb1c7cc6e404593b62e79b1fb815bc65ff49cae | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 177 | 49 | 3 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-04 | 177 | 49 | 3 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 7.24e-08 | 104 | 47 | 6 | ctd:C000595015 | |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.70e-07 | 200 | 47 | 7 | 2894_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.76e-06 | 193 | 47 | 6 | 2852_UP | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.11e-06 | 197 | 47 | 6 | 3456_DN | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 4.66e-05 | 192 | 47 | 5 | 1829_UP | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.77e-05 | 193 | 47 | 5 | 6757_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 6770_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 5.14e-05 | 196 | 47 | 5 | 2072_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 4475_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 7177_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 6969_UP | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 4530_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 4550_DN | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 3305_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 4251_UP | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 4068_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 6244_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 6826_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; HL60; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 2572_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 5.65e-05 | 200 | 47 | 5 | 7015_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; PC3; HT_HG-U133A | 5.65e-05 | 200 | 47 | 5 | 5737_UP | |
| Disease | chronotype measurement | 6.68e-07 | 882 | 45 | 10 | EFO_0008328 | |
| Disease | glucagon-like peptide-1 measurement | 1.02e-04 | 10 | 45 | 2 | EFO_0008465 | |
| Disease | feeling miserable measurement | 2.42e-04 | 79 | 45 | 3 | EFO_0009598 | |
| Disease | S-7-hydroxywarfarin to S-warfarin ratio measurement | 2.60e-04 | 81 | 45 | 3 | EFO_0803334 | |
| Disease | BRCAX breast cancer | 4.25e-04 | 20 | 45 | 2 | EFO_0009443 | |
| Disease | suicidal ideation, suicide behaviour | 6.14e-04 | 24 | 45 | 2 | EFO_0004320, EFO_0007623 | |
| Disease | Drug habituation | 7.26e-04 | 115 | 45 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 7.26e-04 | 115 | 45 | 3 | C0236969 | |
| Disease | Drug abuse | 7.26e-04 | 115 | 45 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 7.26e-04 | 115 | 45 | 3 | C0013222 | |
| Disease | Drug Dependence | 7.26e-04 | 115 | 45 | 3 | C1510472 | |
| Disease | Substance Dependence | 7.26e-04 | 115 | 45 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 7.26e-04 | 115 | 45 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 7.26e-04 | 115 | 45 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 7.26e-04 | 115 | 45 | 3 | C4316881 | |
| Disease | Substance abuse problem | 7.45e-04 | 116 | 45 | 3 | C0740858 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 8.38e-04 | 28 | 45 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | Parkinsonism (implicated_via_orthology) | 8.99e-04 | 29 | 45 | 2 | DOID:0080855 (implicated_via_orthology) | |
| Disease | Marijuana Abuse | 9.63e-04 | 30 | 45 | 2 | C0024809 | |
| Disease | cannabis dependence | 1.15e-03 | 135 | 45 | 3 | EFO_0007191 | |
| Disease | chronic kidney disease, diabetic nephropathy | 1.39e-03 | 36 | 45 | 2 | EFO_0000401, EFO_0003884 | |
| Disease | breast cancer, ovarian carcinoma | 1.46e-03 | 37 | 45 | 2 | EFO_0001075, MONDO_0007254 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 1.54e-03 | 38 | 45 | 2 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | unipolar depression, bipolar disorder | 1.75e-03 | 156 | 45 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | age at first sexual intercourse measurement | 2.74e-03 | 383 | 45 | 4 | EFO_0009749 | |
| Disease | femoral neck bone mineral density | 3.34e-03 | 196 | 45 | 3 | EFO_0007785 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 3.53e-03 | 200 | 45 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | eye colour measurement | 4.49e-03 | 218 | 45 | 3 | EFO_0009764 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPPPLPSQPSLKPQQ | 106 | Q9NP70 | |
| PLHHEPPPPLLKTNN | 461 | P42568 | |
| TPDLPQPHLPPISAP | 816 | Q12774 | |
| PLPTHPHLPAPIPSS | 2616 | Q8IYW2 | |
| LTSIPHAHPPEPPPL | 261 | O94983 | |
| PPPPQPHLLHCPLLA | 891 | Q96M86 | |
| PQPPKSFPLHPQPVT | 416 | Q9NVE4 | |
| LPPPPQPHPSLDELH | 741 | Q5TC82 | |
| LQPLLPVQHPHHPSP | 341 | Q96EV2 | |
| PTHTQPNLQGPLHPP | 571 | Q96EV2 | |
| PPQQPLPLQHPHLFP | 971 | Q9H3S7 | |
| LPLQHPHLFPPQAPG | 976 | Q9H3S7 | |
| ALVPPVIPNHPPSNP | 431 | Q96QZ7 | |
| PQSPLSPHSPIPPHP | 1421 | Q5JU85 | |
| LPPDPPPLTVPQTHN | 161 | Q8N5H3 | |
| LHPPPQLSPFLQPHG | 111 | P03372 | |
| HAPPQTLQHPQGIPP | 166 | Q8WU58 | |
| APLPPQPAQPHLPQA | 76 | P09086 | |
| RPTLPDPHLSHPQPP | 171 | P09086 | |
| PPPSPQLPKHNLHVT | 141 | Q14678 | |
| PPPIQVSALHHSPPL | 1211 | Q9BZA7 | |
| PNRHFHPLPQLPRPP | 1356 | P42694 | |
| QHLPQPPLGLHQPPV | 1541 | P42694 | |
| ALPHPPPTHLSVPPR | 121 | Q8TB68 | |
| CHLPRPPQHLSPPQP | 166 | I0J062 | |
| PHQRHLPPPLPSKTP | 1831 | Q14185 | |
| PPLPPLVVFNHLTPP | 36 | P51451 | |
| SPIPPSHHQLTLPDP | 296 | P14416 | |
| PHKSPTPPPTLHLVP | 916 | Q9NZM4 | |
| ALDPVHQPPPPPATL | 1326 | Q9NZM4 | |
| PPALSSNPHQLLPPP | 1191 | P39059 | |
| PPALLQPPEVPVPHS | 461 | Q14872 | |
| PSLLASPPLQAPPHP | 551 | Q9H6K5 | |
| ILPPQAHLVPPPSDP | 616 | Q9Y6C5 | |
| QLSPRSHLCPPPPHP | 11 | Q7Z4S9 | |
| SHLCPPPPHPTPPQL | 16 | Q7Z4S9 | |
| PPPHPTPPQLNNLLL | 21 | Q7Z4S9 | |
| STLRPPLPPPHNHTL | 246 | Q9NT68 | |
| PPQQLPFPLLPPHHI | 236 | Q6ZUB0 | |
| PPTTPIPQLPAPQAH | 931 | Q9P2R6 | |
| PNQPHLPQPHLPHLP | 191 | Q15714 | |
| PPPPQLLPSVLSHAP | 796 | Q9ULL5 | |
| ILPVHILPSPPPPSQ | 2476 | Q6ZRS2 | |
| SSLHTPLALPPPQPP | 131 | Q9HB58 | |
| PQPPHPALAPHLPTE | 56 | Q6S5L8 | |
| PPQQLPFPLLPPHHI | 236 | P0C874 | |
| TVPQPHPQTLPPAVP | 331 | O14776 | |
| PAPHLLQPGPQHVLP | 211 | Q8TDD2 | |
| DHSPPQQLPFPLLPP | 236 | Q6ZQQ2 | |
| QSLQPPPHPPLLHPT | 256 | Q6H3X3 | |
| HHHPPQPPSPLLLLP | 666 | Q2VWA4 | |
| LQLTQEPGPPPPTHH | 671 | O43167 | |
| LSQAPPSHIPPPPRH | 301 | O95049 | |
| LQPLSHHAPPVPLTP | 126 | Q04725 | |
| SPPPPLQISPPLHQH | 416 | O94900 | |
| LPPKPAHLTQSHPPQ | 1326 | Q702N8 |